tradingkey.logo
搜索

Progyny Inc

PGNY
添加自选
23.250USD
+0.380+1.66%
收盘 05/15, 16:00美东报价延迟15分钟
1.82B总市值
28.83市盈率 TTM

Progyny Inc

23.250
+0.380+1.66%
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.66%

5天

-1.98%

1月

+29.67%

6月

-5.30%

今年开始到现在

-9.46%

1年

+4.26%

TradingKey Progyny Inc股票评分

单位: USD 更新时间: 2026-05-15

操作建议

Progyny Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗服务供应商行业排名6/74位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价28.18。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Progyny Inc评分

相关信息

行业排名
6 / 74
全市场排名
50 / 4482
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Progyny Inc亮点

亮点风险
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
业绩高增长
公司营业收入稳步增长,连续3年增长18.38%
估值低估
公司最新PE估值28.83,处于3年历史低位
机构减仓
最新机构持股88.51M股,环比减少26.54%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓,最新持仓市值1.52K

分析师目标

根据 11 位分析师
买入
评级
28.182
目标均价
+23.23%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Progyny Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Progyny Inc简介

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
公司代码PGNY
公司Progyny Inc
CEOAnevski (Peter)
网址https://www.progyny.com/
KeyAI